Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Who's Promised What: A Guide To Pharma Drug Pricing Pledges

Executive Summary

Pharma companies have responded to mounting political pressure to lower drug prices by pledging to limit increases and even roll back the costs of certain drugs, but it's hard to keep track of who has promised what exactly. Here, Scrip provides a listing of pharma pricing pledges.


Related Content

Scrip’s Top Five Stories Of 2018
The Inevitable Is Coming: Price Increases, Starting With Pfizer
US Drug Pricing Challenges Poised To Impact Pharma Growth, Leerink Warns
A Renewal Begins For Bausch (Née Valeant), But Challenges Ahead
Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump
Pricing Positives From Trump Plan Include Potential 340B Changes, Value-Based Contracts
A US Drug Pricing Rebellion Looms, Analyst Says
The Ups and Downs Of US Drug Pricing Policy
Saunders: Industry Must Act Before We Lose Champions For Innovation In Congress
Allergan's Price Reform Pledge: Will Others Follow?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts